96793 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses Orthomyxoviridae, e.g. influenza virus
M1 VIRUS MUTANT AND USE THEREOF
#2SELF-REPLICATING RNA AND USE THEREOF
#3PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY
#4MODIFIED INFLUENZA VIRUSES
#5COMPOSITIONS INCLUDING SBI ADJUVANTS AND METHODS OF USE THEREOF
#6INFLUENZA VIRUS VACCINATION REGIMENS
#7VACCINE ANTIGENS AND USE THEREOF
#8Immunogenic Compositions to Treat and Prevent Microbial Infections
#9INFLUENZA VIRUS HEMAGGLUTININ MUTANTS
#10SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES
#11Vaccines for the Treatment and Prevention of Zoonotic Infections
#12IMMUNOGENIC COMPOSITION AND USES THEREOF
#13TRANSDERMAL ACTIVE AGENT DELIVERY DEVICES HAVING CORONAVIRUS VACCINE COATED MICRO-PROTRUSIONS
#14Immunogenic Compositions to Treat and Prevent Microbial Infections
#15COMPOSITIONS INCLUDING SBI ADJUVANTS AND METHODS OF USE THEREOF
#16HERPES SIMPLEX VIRUS TYPE 1 DERIVED INFLUENZA VACCINE
#17MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY
#18HA STEM VACCINE FOR HA ANTIBODY-POSITIVE TARGETS
#19MULTICISTRONIC RNA VACCINES AND USES THEREOF
#20Influenza vaccines
#21TARGETED ANTIGEN DELIVERY SYSTEM AND USES THEREOF
#22INFLUENZA VIRUS BACKBONE
#23Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same
#24EDIBLE CELL BASED VACCINES
#25SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT HAVING A SPECIFIC ORDER OF GENES
#26FUSION PROTEIN COMPRISING BP26 AND ANTIGENIC POLYPEPTIDE
#27VACCINE USING M2/BM2-DEFICIENT INFLUENZA VECTORS
#28Recombinant Nucleic Acid Construct Encoding Influenza Peptides and Compositions
#29RNA VACCINES
#30Methods of optimizing nucleotide sequences encoding engineered influenza proteins
#31Compositions including SBI adjuvants and methods of use thereof
#32M1 VIRUS MUTANT AND USE THEREOF
#33Vaccines for the Treatment and Prevention of Zoonotic Infections
#34Pepmixes to generate multiviral CTLS with broad specificity
#35Ii vaccine adjuvant
#36Influenza vaccines
#37FUSION PROTEIN
#38Peptides for inducing heterosubtypic influenza T cell responses
#39Influenza virus hemagglutinin mutants
#40Pepmixes to generate multiviral CTLs with broad specificity
#41INFLUENZA VIRUS HEMAGGLUTINIIN MUTANTS
#42Immunogenic compositions to treat and prevent microbial infections
#43SYSTEMS, METHODS, AND CELL LINES FOR GENERATING INFLUENZA VIRUS OR INFLUENZA VIRUS PROTEINS
#44Influenza virus hemagglutinin mutants
#45Self-assembling insect ferritin nanoparticles
#46ENGINEERED INFLUENZA ANTIGENIC POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS THEREOF
#47Methods of optimizing nucleotide sequences encoding engineered influenza proteins
#48Methods of generating broadly protective vaccine compositions comprising hemagglutinin
#49Influenza peptides and compositions
#50Hepatitis B nanoparticle-based vaccine for influenza virus
#51COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA
#52Transkingdom platform for therapeutic nucleic acid delivery
#53Ii vaccine adjuvant
#54Influenza Peptides and Compositions
#55Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
#56INFLUENZA HEMAGGLUTININ PROTEIN VACCINES
#57Compositions and methods for vaccination against influenza
#58Adenoviral vector system for gene delivery
#59Hemagglutinin-binding peptide
#60Re-directed immunotherapy
#61Influenza mucosal vaccine composition and preparation and application thereof
#62Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same
#63Influenza peptides and compositions
#64Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#65METHODS FOR IMPROVING THE EFFICACY OF VACCINE ANTIGENS
#66Antiviral peptide and use therefor
#67Antibody capable of binding to intranuclear protein of influenza virus, composite, detection device and method using same
#68Antibody capable of binding to intranuclear protein of influenza virus, composite, detection device and method using same
#69Influenza virus vaccines and uses thereof
#70COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA
#71Turkey herpesvirus vectored recombinant containing avian influenza genes
#72Dps fusion proteins for use in vaccines and diagnostics
#73Vaccine composition for classical swine fever from plant and manufacturing method thereof
#74Characterization of influenza vaccines
#75Recombinant Influenza Virus
#76Influenza vaccines
#77Peptide sequences and compositions
#78Methods of optimizing nucleotide sequences encoding engineered influenza proteins
#79METHODS FOR IMPROVING THE EFFICACY OF VACCINE ANTIGENS
#80Peptide sequences and compositions
#81Versatile influenza virus vaccine composition
#82Modified CPMV enhancer elements
#83Influenza virus vaccination regimens
#84Influenza virus vaccines and uses thereof
#85Hemagglutinin-binding peptide
#86Turkey herpesvirus vectored recombinant containing avian influenza genes
#87Influenza virus vaccines and uses thereof
#88Influenza virus vaccines and uses thereof
#89Vaccines for use in the prophylaxis and treatment of influenza virus disease
#90Peptide sequences and compositions
#91Peptidomimetic macrocycles
#92Broad spectrum influenza A neutralizing vaccines and D-peptidic compounds, and methods for making and using the same
#93Influenza nucleoprotein vaccines
#94High affinity synbodies for influenza
#95Dps fusion proteins for use in vaccines and diagnostics
#96Polypeptides for treating and/or limiting influenza infection
#97Flagellin fusion proteins
#98Deletion mutants of flagellin and methods of use
#99Deletion mutants of flagellin and methods of use
#100RECOMBINANT AVIAN INFLUENZA VACCINE AND USES THEREOF
#101Peptide sequences and compositions
#102Methods of making hemagglutinin proteins
#103UNIVERSAL INFLUENZA A VACCINES
#104Vaccines for use in the prophylaxis and treatment of influenza virus disease
#105Composite antigenic sequences and vaccines
#106Computationally optimized broadly reactive antigens for influenza
#107Broad spectrum influenza A neutralizing vaccines and D-peptidic compounds, and methods for making and using the same
#108INFLUENZA VACCINE
#109DPS fusion proteins for use in vaccines and diagnostics
#110Influenza hemagglutinin and neuraminidase variants
#111B-cell stimulating fusion proteins of an antigen with BAFF or APRIL
#112Methods of treatment with compositions that include hemagglutinin
#113Expression of proteins in plants
#114Influenza virus vaccine and uses thereof
#115Swine influenza hemagglutinin variants
#116Therapy for influenza like illness
#117Peptide sequences and compositions
#118Influenza hemagglutinin and neuraminidase variants
#119Deletion mutants of flagellin and methods of use
#120Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof
#121INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#122Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
#123Turkey herpesvirus vectored recombinant containing avian influenza genes
#124Peptide sequences and compositions
#125Expression of proteins in plants
#126Influenza Hemagglutinin And Neuraminidase Variants
#127Turkey herpesvirus vectored recombinant containing avian influenza genes
#128Compositions that include hemagglutinin
#129Compositions that include hemagglutinin, methods of making and methods of use thereof